Nucleic Acid Isolation Kit

Nucleic Acid Isolation Kit Market Outlook

The global nucleic acid isolation kit market was valued at approximately USD 2.5 billion in 2022 and is projected to reach around USD 4.1 billion by 2035, growing at a CAGR of about 5.3% during the forecast period from 2025 to 2035. This growth can be attributed to the increasing demand for nucleic acid-based diagnostics, the rapid advancement of personalized medicine, and a significant surge in research and development activities across various fields, including biotechnology, pharmaceuticals, and molecular biology. Moreover, the rise in infectious diseases and genetic disorders has further stimulated the need for efficient and effective nucleic acid isolation techniques. The growing emphasis on early disease detection and treatment, alongside the proliferation of research initiatives, is expected to fuel market expansion, paving the way for innovative product offerings and improved methodologies in nucleic acid extraction.

Growth Factor of the Market

The nucleic acid isolation kit market is experiencing substantial growth, primarily driven by the increasing prevalence of genetic disorders and infectious diseases, which necessitate effective diagnostic solutions. As the field of genomics continues to evolve, there is a growing demand for high-purity nucleic acids, which are essential for accurate analyses and testing. Innovations in extraction technologies, such as magnetic bead-based methods and spin column techniques, have improved efficiency and reduced processing times, making these kits more appealing to laboratories and research institutions. Furthermore, the expansion of molecular biology research and the rising adoption of personalized medicine are prompting a surge in the utilization of nucleic acid isolation kits. The COVID-19 pandemic has also underscored the importance of nucleic acid testing, boosting the market for these kits as diagnostic solutions become increasingly critical in public health responses. Overall, these factors are expected to contribute positively to the nucleic acid isolation kit market's growth trajectory.

Key Highlights of the Market

• The market is driven by advancements in extraction technologies and the growing prevalence of genetic diseases.
• North America is anticipated to lead the market due to robust research infrastructure and high healthcare expenditure.
• Online distribution channels are gaining popularity, facilitating easier access to nucleic acid isolation kits.
• Research applications dominate the market, reflecting the critical role of nucleic acid testing in scientific advancements.
• The COVID-19 pandemic has significantly boosted the demand for nucleic acid isolation kits for diagnostic purposes.

By Product Type

Genomic DNA Isolation Kits:

Genomic DNA isolation kits are specifically designed for the extraction and purification of genomic DNA from various biological samples. These kits are extensively used in molecular biology, genetics, and genomics research. The demand for genomic DNA isolation kits is propelled by the increasing prevalence of genetic testing, as more laboratories adopt these kits for high-quality DNA extraction. The availability of different protocols tailored for diverse sample types, such as blood, tissue, and cells, further enhances their appeal among researchers. Additionally, the rising number of genomic studies and the push towards personalized medicine are expected to foster the growth of this segment in the nucleic acid isolation kit market.

Plasmid DNA Isolation Kits:

Plasmid DNA isolation kits are integral tools for researchers focusing on molecular cloning and recombinant DNA technology. These kits are specifically designed to extract plasmid DNA from bacterial cultures, enabling the analysis and manipulation of genetic material. The increasing applications of plasmid DNA in vaccine development, gene therapy, and synthetic biology are propelling the growth of this segment. Moreover, improvements in extraction methodologies that enhance yield and purity have made these kits more attractive to academic and commercial laboratories. Consequently, the demand for plasmid DNA isolation kits is expected to rise steadily in the coming years.

Total RNA Isolation Kits:

Total RNA isolation kits are essential for extracting RNA from a variety of biological samples, including cells and tissues. The growing focus on transcriptomics and gene expression studies is driving the demand for these kits, as researchers require high-quality RNA for their experiments. The total RNA isolation process involves several steps, including cell lysis, RNA extraction, and purification, which can be efficiently achieved using these kits. Furthermore, advancements in extraction techniques that allow for faster processing times and improved yields are contributing to the growth of the total RNA isolation segment in the nucleic acid isolation kit market.

microRNA Isolation Kits:

MicroRNA isolation kits are specialized for the extraction and purification of microRNAs, which play a crucial role in gene regulation and various biological processes. The rising interest in microRNA research, particularly in oncology and developmental biology, is driving the demand for these kits. Given their small size and the complexity of their extraction, microRNA isolation kits are designed with specific protocols to ensure high yield and purity. As the understanding of microRNAs expands and their potential as biomarkers for disease diagnosis is recognized, the market for microRNA isolation kits is expected to witness significant growth.

mRNA Isolation Kits:

mRNA isolation kits are vital for extracting messenger RNA, which serves as a template for protein synthesis. The demand for mRNA isolation kits is propelled by the increasing focus on transcriptomics research and the burgeoning field of mRNA therapeutics, including vaccines and gene therapies. These kits often utilize advanced techniques to ensure the integrity and yield of mRNA, making them indispensable tools in molecular biology. The ongoing developments in mRNA technology and the growing number of applications in clinical research and diagnostics are expected to further enhance the growth of this segment in the nucleic acid isolation kit market.

By Application

Research:

Research accounts for a significant share of the nucleic acid isolation kit market, as these kits are essential tools in various scientific studies, including genetics, molecular biology, and biotechnology. Researchers utilize nucleic acid isolation kits to extract DNA, RNA, and other nucleic acids for analyses, cloning, sequencing, and other applications. The growing investment in research and development across academic institutions and biotechnology companies fuels this segment's growth. Moreover, the increasing number of genomic and proteomic studies is driving demand for high-quality nucleic acids, further enhancing the relevance of nucleic acid isolation kits in research.

Diagnostics:

The diagnostics segment is witnessing robust growth, largely driven by the rising need for molecular diagnostics in clinical settings. Nucleic acid isolation kits are pivotal in the detection of infectious diseases, genetic disorders, and various cancers. With the growing emphasis on early disease detection and the need for accurate diagnostic tools, the adoption of nucleic acid-based tests is increasing. Furthermore, advancements in point-of-care testing and the expansion of molecular testing capabilities in hospitals and diagnostic laboratories are expected to bolster the demand for nucleic acid isolation kits in this application area.

Drug Discovery:

In the drug discovery sector, nucleic acid isolation kits are utilized extensively for target validation, biomarker discovery, and preclinical studies. The need for efficient and high-throughput isolation methods is driving the demand for these kits, as pharmaceutical and biotechnology companies seek to streamline their drug discovery processes. The increasing investments in drug development, particularly in personalized medicine and genomics-based therapies, are contributing to the growth of this segment. As the pharmaceutical industry continues to evolve, the reliance on nucleic acid isolation kits will likely expand, underscoring their importance in drug discovery.

Other Applications:

Other applications of nucleic acid isolation kits include forensic analysis, environmental monitoring, and agricultural biotechnology. These kits are employed in various fields to extract nucleic acids from diverse samples for subsequent analysis. The growing interest in forensic science and the need for accurate DNA profiling are driving demand in this area. Additionally, the use of nucleic acid isolation kits in environmental monitoring for detecting pathogens in water and soil samples further enhances their versatility. The agricultural sector is also increasingly utilizing these kits for plant breeding and genetic modification studies, contributing to the overall growth of the market.

By Distribution Channel

Online Stores:

Online stores have emerged as a significant distribution channel for nucleic acid isolation kits, offering customers the convenience of purchasing products from the comfort of their homes or laboratories. The proliferation of e-commerce and the growing trend of online shopping have made it easier for researchers and laboratories to access various nucleic acid isolation kits. Online platforms provide detailed product information, customer reviews, and competitive pricing, making them increasingly popular among end-users. This distribution channel is expected to continue growing as more companies enhance their online presence and streamline their logistics systems.

Biotech Companies:

Biotech companies play a pivotal role in the distribution of nucleic acid isolation kits, as they often develop and manufacture these products. These companies typically have established networks and relationships with research institutions, hospitals, and diagnostic labs, facilitating the distribution of their kits. The growing number of biotech startups and established firms increasingly focusing on the development of innovative nucleic acid isolation solutions is driving the segment's growth. As the demand for high-quality and specialized nucleic acid isolation kits increases, biotech companies stand to benefit significantly from market developments.

Research Institutes:

Research institutes are key players in the distribution of nucleic acid isolation kits, as they often require these kits for their scientific studies. Many institutes collaborate with kit manufacturers to ensure they have access to the latest technologies and methodologies in nucleic acid isolation. The increasing number of research initiatives and projects in biotechnology and molecular biology is propelling the demand for nucleic acid isolation kits in this segment. As research institutes continue to expand their capabilities, the distribution of these kits will likely grow in line with their evolving needs.

Hospitals & Diagnostic Centers:

Hospitals and diagnostic centers represent a crucial distribution channel for nucleic acid isolation kits, as they rely on these products for molecular diagnostics and testing. The rising demand for accurate diagnostic solutions in clinical settings is resulting in increased adoption of nucleic acid isolation kits. These centers often prefer kits that offer fast processing times and high yields, as they aim to improve patient outcomes through timely and effective testing. The continuous advancements in diagnostic technologies further enhance the relevance of nucleic acid isolation kits in hospitals and diagnostic centers, driving demand in this segment.

Other Distribution Channels:

Other distribution channels for nucleic acid isolation kits include medical supply companies, laboratory equipment suppliers, and wholesalers. These channels cater to a diverse clientele, including research laboratories, biotechnology firms, and academic institutions. The growth of these alternative channels is driven by the increasing need for nucleic acid isolation solutions across various sectors. As demand for nucleic acid testing continues to rise, the presence of these distribution channels will play a vital role in ensuring that end-users can access the necessary products efficiently.

By Sample Type

Blood:

Blood is one of the most common sample types utilized for nucleic acid isolation, primarily due to its ease of collection and rich source of genetic material. Nucleic acid isolation kits designed for blood samples are specifically optimized to extract high-quality DNA and RNA, which are essential for various applications, including genetic testing and infectious disease diagnostics. The increasing prevalence of blood-related disorders and the growing demand for liquid biopsies are driving the market for blood sample-based nucleic acid isolation kits. As research and clinical applications continue to expand, the reliance on these kits for blood samples will likely increase significantly.

Tissue:

Tissue samples are another significant source of nucleic acids, making nucleic acid isolation kits for tissue extraction crucial for numerous research and clinical applications. These kits are designed to efficiently extract high-quality DNA and RNA from various types of tissues, including solid tumors and healthy biopsy samples. The increasing focus on cancer research and personalized medicine is propelling the demand for tissue sample nucleic acid isolation kits, as they play a key role in understanding tumor biology and genetic profiling. As advancements in tissue preservation and processing technologies continue, the relevance of these kits is expected to grow accordingly.

Cells:

Cell samples are widely used in molecular biology studies, and nucleic acid isolation kits are essential for extracting nucleic acids from both adherent and suspension cell cultures. These kits are designed to efficiently lyse cells and purify DNA and RNA while preserving their integrity for downstream applications. The rising interest in cell-based therapies, immunology, and stem cell research is driving the demand for nucleic acid isolation kits tailored for cell samples. As researchers increasingly rely on these kits for their studies, the market for cell sample nucleic acid isolation solutions will continue to expand.

Saliva:

Saliva is an emerging sample type for nucleic acid isolation, offering a non-invasive alternative to blood and tissue samples. Nucleic acid isolation kits for saliva are designed to provide high yields of DNA and RNA, making them suitable for various applications, including genetic testing and oral health research. The growing interest in personalized medicine and direct-to-consumer genetic testing is driving the demand for saliva-based nucleic acid isolation kits. As the acceptance and utilization of saliva as a sample type continue to rise, the market for these kits is poised for significant growth in the coming years.

Other Sample Types:

Other sample types for nucleic acid isolation include urine, feces, and environmental samples, which are gaining traction in various research fields. Nucleic acid isolation kits tailored for these sample types are specifically designed to address the unique challenges associated with extracting nucleic acids from diverse matrices. The rising interest in microbiome research and environmental monitoring is propelling the demand for these kits, as they enable the study of microbial communities and pathogen detection. As research expands into new areas, the relevance and application of nucleic acid isolation kits for other sample types will continue to grow.

By Region

The North American region is anticipated to dominate the nucleic acid isolation kit market due to its well-established healthcare infrastructure, advanced research facilities, and high investment in biotech innovation. The region's focus on personalized medicine and the increasing prevalence of genetic disorders and infectious diseases are driving the demand for nucleic acid isolation kits. In 2022, the North American market was estimated to be worth around USD 1.1 billion, and it is projected to grow at a CAGR of 5.8% through 2035. Additionally, the presence of major biotechnology companies and research institutions further enhances the region's growth prospects in this market.

Europe is another key region in the nucleic acid isolation kit market, characterized by its strong investment in research and development and growing focus on advanced diagnostic technologies. The European market was valued at approximately USD 800 million in 2022 and is expected to witness steady growth due to increasing collaborations between research institutions and biotech companies. The rising emphasis on personalized medicine and the growing number of clinical trials in Europe are also expected to contribute to the demand for nucleic acid isolation kits in the region. As the market evolves, European manufacturers are likely to focus on developing innovative and specialized kits to meet the diverse needs of researchers and healthcare professionals.

Opportunities

One of the most significant opportunities in the nucleic acid isolation kit market lies in the burgeoning field of personalized medicine. As healthcare shifts towards more individualized therapeutic approaches, the demand for high-quality nucleic acid extraction becomes increasingly critical. Biopharmaceutical companies are investing heavily in research and development to create targeted therapies based on genetic information, which necessitates robust nucleic acid isolation methods. This trend presents a substantial opportunity for kit manufacturers to innovate and expand their product offerings to meet the evolving needs of personalized medicine, thereby capturing a larger share of the market.

Another promising opportunity stems from the rising interest in next-generation sequencing (NGS) applications. NGS technologies require high-quality nucleic acids for accurate sequencing results, and there is a growing demand for nucleic acid isolation kits specifically designed for NGS workflows. As more laboratories adopt NGS for genomics research, clinical diagnostics, and drug discovery, the need for reliable and efficient nucleic acid isolation solutions will continue to grow. Companies that can develop specialized kits to cater to the NGS market will find themselves well-positioned to capitalize on this expanding opportunity, thereby contributing to the overall growth of the nucleic acid isolation kit market.

Threats

One of the primary threats facing the nucleic acid isolation kit market is the rapid pace of technological advancements in extraction methodologies. While innovation is generally positive, it can also lead to market fragmentation, with numerous competitors introducing novel extraction technologies that may outperform existing products. This constant evolution of technology may force established companies to continuously adapt and innovate to remain relevant in the market. Furthermore, the emergence of alternative extraction methods and competitors offering lower-cost solutions may impact the profit margins of traditional kit manufacturers. To stay competitive, companies must invest in research and development to continually enhance their product offerings and maintain a strong market presence.

Another concern for the nucleic acid isolation kit market is the potential regulatory challenges that can arise in different regions. The healthcare and biotechnology industries are subject to stringent regulations, and any changes in regulatory frameworks can impact the approval and availability of nucleic acid isolation kits. Companies may face delays in product launches or increased costs due to compliance requirements, which could hinder growth. Additionally, as the market expands globally, navigating varying regulatory landscapes can be complex and may pose a significant barrier for companies seeking to penetrate new markets. As such, it is crucial for manufacturers to remain aware of regulatory developments and ensure their products meet all necessary standards.

Competitor Outlook

• Thermo Fisher Scientific
• Qiagen
• Merck KGaA
• Promega Corporation
• Bio-Rad Laboratories
• New England Biolabs
• Zymo Research Corporation
• Omega Bio-tek
• Agilent Technologies
• Fisher Scientific
• Takara Bio Inc.
• GenScript
• Bioline
• MilliporeSigma
• Roche

The competitive landscape of the nucleic acid isolation kit market is characterized by a mix of established players and emerging companies, all vying for market share in a rapidly evolving industry. Major participants, such as Thermo Fisher Scientific and Qiagen, have a strong presence due to their extensive product portfolios, robust distribution networks, and ongoing investments in research and development. These companies continually strive to innovate and enhance their nucleic acid isolation kits, ensuring that they remain at the forefront of technological advancements. The market is also witnessing an influx of smaller biotech firms that specialize in niche applications, creating additional competition and opportunities for collaboration within the industry.

In addition to product innovation, companies are focusing on strategic partnerships and collaborations to expand their reach and capabilities in the nucleic acid isolation kit market. For instance, partnerships between leading biotech firms and academic institutions are fostering the development of new extraction technologies and applications. This collaborative approach not only enhances product offerings but also accelerates the introduction of cutting-edge solutions to the market. Moreover, companies are increasingly adopting digital marketing strategies and e-commerce platforms to reach a broader audience and improve their customer engagement, which is essential in a competitive landscape.

Among the key players, Thermo Fisher Scientific stands out for its comprehensive portfolio of nucleic acid isolation products and its commitment to innovation. The company invests significantly in research and development, ensuring it can offer state-of-the-art extraction technologies tailored for a variety of applications, including genomics and diagnostics. Qiagen is another formidable competitor, known for its expertise in sample and assay technologies. The company's nucleic acid isolation kits are widely used across research, clinical, and applied markets, making it a trusted name among researchers and healthcare professionals. Both companies are likely to continue playing a significant role in shaping the future of the nucleic acid isolation kit market as they respond to emerging trends and evolving customer needs.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Roche
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Qiagen
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Bioline
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 GenScript
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Merck KGaA
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Omega Bio-tek
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 MilliporeSigma
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Takara Bio Inc.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Fisher Scientific
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 New England Biolabs
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Promega Corporation
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Agilent Technologies
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Bio-Rad Laboratories
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Thermo Fisher Scientific
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Zymo Research Corporation
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Nucleic Acid Isolation Kit Market, By Application
    • 6.1.1 Research
    • 6.1.2 Diagnostics
    • 6.1.3 Drug Discovery
    • 6.1.4 Other Applications
  • 6.2 Nucleic Acid Isolation Kit Market, By Sample Type
    • 6.2.1 Blood
    • 6.2.2 Tissue
    • 6.2.3 Cells
    • 6.2.4 Saliva
    • 6.2.5 Other Sample Types
  • 6.3 Nucleic Acid Isolation Kit Market, By Product Type
    • 6.3.1 Genomic DNA Isolation Kits
    • 6.3.2 Plasmid DNA Isolation Kits
    • 6.3.3 Total RNA Isolation Kits
    • 6.3.4 microRNA Isolation Kits
    • 6.3.5 mRNA Isolation Kits
  • 6.4 Nucleic Acid Isolation Kit Market, By Distribution Channel
    • 6.4.1 Online Stores
    • 6.4.2 Biotech Companies
    • 6.4.3 Research Institutes
    • 6.4.4 Hospitals & Diagnostic Centers
    • 6.4.5 Other Distribution Channels

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Nucleic Acid Isolation Kit Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Nucleic Acid Isolation Kit market is categorized based on

By Product Type

• Genomic DNA Isolation Kits
• Plasmid DNA Isolation Kits
• Total RNA Isolation Kits
• microRNA Isolation Kits
• mRNA Isolation Kits

By Application

• Research
• Diagnostics
• Drug Discovery
• Other Applications

By Distribution Channel

• Online Stores
• Biotech Companies
• Research Institutes
• Hospitals & Diagnostic Centers
• Other Distribution Channels

By Sample Type

• Blood
• Tissue
• Cells
• Saliva
• Other Sample Types

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Thermo Fisher Scientific
• Qiagen
• Merck KGaA
• Promega Corporation
• Bio-Rad Laboratories
• New England Biolabs
• Zymo Research Corporation
• Omega Bio-tek
• Agilent Technologies
• Fisher Scientific
• Takara Bio Inc.
• GenScript
• Bioline
• MilliporeSigma
• Roche